Should moderate acute rejection of a cardiac transplant graft be treated?

Clinical Transplantation

Volumn 16, Issue 3, 2002, Pages 217-221

  Delgado, D H ^a   Luu, L ^b   Edwards, J ^b   Cardella, C ^a   Rao, Vivek ^a   Ross, H J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Heart transplant; Immuno suppressants; Rejection

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG USE; ECHOCARDIOGRAPHY; FEMALE; GRAFT REJECTION; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; INFECTION; MALE; MEDICAL DECISION MAKING; METABOLIC DISORDER; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT; TIME;

ADOLESCENT; ADULT; BIOPSY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0036300861     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2002.01132.x     Document Type: Article

References (16)

1. Evolution of focal moderate (International Society for Heart and Lung Transplantation Grade 2) rejection of the cardiac allograft
2. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation Grade) early and late after transplantation
3. Repetitive non treated episodes of grade 1B or 2 acute rejection impair long-term cardiac graft function
4. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation
5. Clinical and laboratory correlates of accelerated coronary artery disease in cardiac transplant patients
6. Prevalence of accelerated coronary artery disease in heart transplant survivors: Comparison of cyclosporine and azathioprine regimens
7. Cardiac allograft vasculopathy
8. Cardiac allograft vasculopathy: Relationship with acute cellular rejection and histocompatibility
9. Cellular rejection and rate of progression f transplant vasculopathy: A 3-year serial intravascular ultrasound study
10. Effect of mycophenolate mofetil on allograft aterioscleosis
11. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: Time for a reappraisal
12. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?
13. Oral steroid pulse without taper for treatment of asyntomatic moderate cardiac allograft rejection
14. Consistencies and controversies in the application of the international society for heart and lung transplantation working formulation for heart transplant biopsy specimens
15. Grade 2 cellular heart rejection: Does it exist?